Identification of degradation impurities in aripiprazole oral solution using LC–MS and development of validated stability indicating method for assay and content of two preservatives by RP-HPLC

References

• WHO. Schizophrenia Fact Sheet N° 397. Geneva: WHO, 2015.
   Google Scholar
• Anderson, I. M.; Haddad, P. M.; Scott, J. Bipolar Disorder. BMJ 2012, 345, e8508.
   PubMed Web of Science ®Google Scholar
• American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington: American Psychiatric Publishing, 2013, 123–154 pp.
   Google Scholar
• Ishiyama, T.; Tokuda, K.; Ishibashi, T.; Ito, A.; Ohno, Y. Lurasidone (SM-13496), A Novel Atypical Antipsychotic Drug, Reverses MK-801-Induced Impairment of Learning and Memory in the Rat Passive-Avoidance Test. Eur. J. Pharmacol. 2007, 572, 160–170.
   PubMed Web of Science ®Google Scholar
• Velligan, D. I.; Kern, R. S.; Gold, J. M. Cognitive Rehabilitation for Schizophrenia and the Putative Role of Motivation and Expectancies. Schizophr. Bull. 2006, 32, 474–485.
   PubMed Web of Science ®Google Scholar
• Kern, R. S.; Green, M. F.; Cornblatt, B. A.; Owen, J. R.; McQuade, R. D.; Carson, W. H.; Ali, M.; Marcus, R. The Neurocognitive Effects of Aripiprazole: An Open-Label Comparison with Olanzapine. Psychopharmacology 2006, 187, 312–320.
   PubMed Web of Science ®Google Scholar
• Pankaj, N.; Parag, G.; Abhishek, C.; Hitendra, M.; Surendra, G. Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage Form. Int. J. Pharm. Sci. Nanotechnol. 2009, 2, 572–581.
   Google Scholar
• Ravindra, N.; Singhvi, I.; Kumara Swamy, G. New RP-HPLC Method for the Estimation of Aripiprazole in Bulk and in Pharmaceutical Dosage Forms. Indo Am. J. Pharm. Res. 2014, 4, 1842–1849.
   Google Scholar
• Raveendra Babu, G.; Srinivasa Rao, J.; Suresh Kumar, K.; Jayachandra Reddy, P. Stability Indicating Liquid Chromatographic Method for Aripiprazole. Asian J. Pharm. Anal. 2011, 1, 03–07.
   Google Scholar
• Srinivasa Rao, N.; Srinivas, P.; Venkataramana, A.; Venkateswara Rao, P. Analytical Method Development Report for Aripiprazole Tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg. Int. J. Adv. Pharm. Biol. Chem. 2012, 1, 377–380.
   Google Scholar
• Nandini, R. P.; Deeptaunshu, A. P. Development and Validation of Liquid Chromatographic Method for Aripiprazole. Der Pharm. Sin. 2012, 3, 526–535.
   Google Scholar
• Prasenjit, M.; Shobha Rani, S.; Alekhya, K. A New Stability Indicating Validated Method for the Determination of Aripiprazole in Bulk and Tablet Dosage Form Using RP-HPLC. Int. J. Pharm. Pharm. Sci. 2013, 5, 660–665.
   Web of Science ®Google Scholar
• Bhadru, B.; Srinath, P.; Kedarnath, J. Development, Estimation and Validation of Aripiprazole in Bulk and Its Pharmaceutical Formulation by HPLC Method. Int. J. Chem Tech Res. 2012, 4, 124–128.
   Google Scholar
• Thakkar, R. S.; Saravaia, H. T.; Ambasana, M. A.; Kaila, H. O.; Sha, A. K. A Chromatographic Determination of Aripiprazole Using HPLC and UPLC: A Comparative Validation Study. Indian J. Pharm. Sci. 2011, 73, 439–443.
   PubMed Web of Science ®Google Scholar
• Srinivas, S. V. K.; Buchireddy, R.; Madhusudhan, G.; Mukkanti, K.; Srinivasulu, P. Stress Degradation Studies on Aripiprazole and Development of a Validated Stability Indicating LC Method. Chromatographia 2008, 68, 635–640.
   Web of Science ®Google Scholar
• Subba Rao, D. V.; Satheesh Kumar, S.; Radhakrishnanand, P.; Himabindu, V. A Stability Indicating RPLC Method for Aripiprazole. Anal. Chem. Indian J. 2008, 7, 444–453.
   Google Scholar
• Vijaya Kumari, M.; Eswaramma, P.; Eswar Kumar, A. V.; Venkata Rao, K.; Narendra Babu, M.; Shabeena Begam, S. K. Analytical Method Validation of Aripiprazole in Pharmaceutical Dosage Form by RP-HPLC. World J. Pharm. Pharm. Sci. 2016, 5, 1168–1179.
   Google Scholar
• Florin, S.; Mihaela, S.; Victor, D. Quantitative Evaluation of Aripiprazole and Its Five Related Chemical Impurities from Pharmaceuticals Using a HPLC-DAD Method. Rev. Roum. Chim. 2014, 59, 1037–1046.
   Web of Science ®Google Scholar
• Katarina, N.; Nataša, D. F.; Borislava, M.; Danica, A.; Nikolic, K.; Filijović, N. D.; Maričić, B.; Agbaba, D. Development of a Novel RP-HPLC Method for the Efficient Separation of Aripiprazole and Its Nine Impurities. J. Sep. Sci. 2013, 36, 3165–3175.
   PubMed Web of Science ®Google Scholar
• Nandini, R. P.; Deepnandan, S. D. Development of Stability Indicating, Validated HPLC Method for Quantitative Determination of Aripiprazole and Its Impurities. Der Pharm. Lett. 2010, 2, 1–10.
   Google Scholar
• Djordjević Filijović, N.; Pavlović, A.; Nikolić, K.; Agbaba, D. Validation of an HPLC Method for Determination of Aripiprazole and Its Impurities in Pharmaceuticals. Acta Chromatogr. 2014, 26, 13–28.
   Web of Science ®Google Scholar
• Narayana, M. B. V.; Chandrasekhar, K. B. A Validated Specific Stability-Indicating RP-HPLC Method for Aripiprazole and Its Related Substances. J. Chem. Pharm. Res. 2012, 4, 4426–4435.
   Google Scholar
• Florin, S.; Mihaela, S.; Victor, D. Dependence of Reversed-Phase Liquid Chromatographic Retention for Aripiprazole and Some Related Chemical Impurities on the Main Elution Parameters. J. Liq. Chromatogr. Relat. Technol. 2016, 39, 70–76.
   Web of Science ®Google Scholar
• Yumiko, A.; Norio Yasui, F.; Midori, K.; Yoshimasa, I.; Tsukasa, U. A Sensitive Column-Switching HPLC method for Aripiprazole and Dehydroaripiprazole and Its Application to Human Pharmacokinetic Studies. J. Sep. Sci. 2010, 33, 3292–3298.
   PubMed Web of Science ®Google Scholar
• Ravinder, S.; Tukaram Bapuji, A.; Mukkanti, K.; Rama Raju, D.; Laxmi Venkata Ravikiran, H.; Chandrapal Reddy, D. Development and Validation of an LC–ESI-MS Method for Quantitative Determination of Aripiprazole in Human Plasma and an Application to Pharmacokinetic Study. J. Chromatogr. Sci. 2012, 50, 893–901.
   PubMed Web of Science ®Google Scholar
• Shen-Nan, L.; Lolita, L.; Thomas, F. N.; Malcolm, S. R.; David, E. M.; Rodger, L. F. A Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry Method for Quantitation of Aripiprazole in Human Plasma. J. Anal. Toxicol. 2009, 33, 237–242.
   PubMed Web of Science ®Google Scholar
• Matteo, C.; Luana, L.; Ilaria, C.; Alessio, S.; Daniela, P.; Simone, D. P.; Paolo, G. An Improved Simple LC–MS/MS Method for the Measurement of Serum Aripiprazole and Its Major Metabolite. J. Pharm. Biomed. Anal. 2012, 62, 135–139.
   PubMed Web of Science ®Google Scholar
• Senthil Kumar, S.; Sushil, J.; Srinivasa Rao, V. Determination of 3-Aminophenol Genotoxic Impurity in Aripiprazole Drug Substances. Inventi Rapid Pharm. Anal. Qual. Assur. 2014, 2015, 1–4.
   Google Scholar
• Venkat Rami Reddy, G.; Praveen Kumar, A.; Venkateswara Reddy, B.; Kumar, P.; Gauttam Ham, D. Identification of Degradation Products in Aripiprazole Tablets by LC-QToF Mass Spectrometry. Eur. J. Chem. 2010, 1, 20–27.
   Google Scholar
• Rowe, R. C.; Sheskey, P. J.; Quinn, M. E. Handbook of Pharmaceutical Excipients. London: Pharmaceutical Press, 2009.
   Google Scholar